Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KRTX

Karuna Therapeutics (KRTX) Stock Price, News & Analysis

Karuna Therapeutics logo

About Karuna Therapeutics Stock (NASDAQ:KRTX)

Advanced Chart

Key Stats

Today's Range
$329.83
$329.83
50-Day Range
$313.97
$329.83
52-Week Range
$158.38
$329.99
Volume
5 shs
Average Volume
832,048 shs
Market Capitalization
$12.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KRTX Stock News Headlines

The day and month stocks are most likely to crash next
Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history gives him 90% historical confidence that stocks will end 2025 up. However, he also has bad news: the same data also tells him the REAL market crash will likely arrive in 2026.
Bristol Myers to Purchase Karuna
See More Headlines

KRTX Stock Analysis - Frequently Asked Questions

Karuna Therapeutics, Inc. (NASDAQ:KRTX) posted its quarterly earnings data on Thursday, February, 22nd. The company reported ($3.01) earnings per share for the quarter, missing analysts' consensus estimates of ($2.65) by $0.36. Karuna Therapeutics's revenue was down 100.0% compared to the same quarter last year.

Karuna Therapeutics (KRTX) raised $70 million in an initial public offering (IPO) on Friday, June 28th 2019. The company issued 4,400,000 shares at a price of $15.00-$17.00 per share. Goldman Sachs, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Karuna Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Palo Alto Networks (PANW), Salesforce (CRM) and Netflix (NFLX).

Company Calendar

Last Earnings
2/22/2024
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KRTX
Fax
N/A
Employees
339
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$433.68 million
Pretax Margin
-66,209.48%

Debt

Sales & Book Value

Annual Sales
$654 thousand
Price / Sales
19,239.07
Price / Cash Flow
N/A
Book Value
$33.24 per share
Price / Book
9.92

Miscellaneous

Free Float
33,157,000
Market Cap
$12.58 billion
Optionable
Optionable
Beta
1.18
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:KRTX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners